James D DeCamp

James D DeCamp is a founding member of Clark+Elbing and a partner since 2002. He enjoys working with clients to understand fully their circumstances and to obtain practical commercial outcomes, efficiently and effectively.

Mr DeCamp counsels clients in nearly all facets of patent law, including global patent prosecution, as well as the preparation of inventorship, patentability, non-infringement and invalidity opinions. He also has extensive experience in handling the complex IP issues that arise during due diligence.

Mr DeCamp handles matters in a spectrum of technologies, including agriculture, life sciences and medicine, biotech, molecular biology and pharmaceutical sciences. His clients include start-ups, large and small companies, universities, medical centres, research institutions and academic inventors from North America, Europe and Asia. In an example of cross-border cooperation, together with in-house and European counsel, Mr DeCamp has successfully defended key patents covering drugs in clinical trials in European opposition proceedings. In other instances, he has deployed with his colleagues strategies for revoking third-party patents. He has also developed a patent portfolio for protecting a humanised monoclonal antibody in clinical development which was licensed to a Fortune 500 company.

As a scientist, Mr DeCamp was a research associate and post-doctoral fellow in the Department of Cellular and Developmental Biology at Harvard University. His research included work in the areas of plant developmental biology, plant storage proteins, chloroplast and nuclear gene expression, chloroplast transformation and protein chemistry.